Innova Captab Promoters Declare No Encumbrance on Shares for FY26 Under SEBI Takeover Regulations

1 min read     Updated on 05 May 2026, 08:05 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Innova Captab Limited's promoters filed a declaration on April 3, 2026, under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, confirming no encumbrance on promoter equity shares for the financial year ended March 31, 2026. The declaration, signed by promoter Vinay Lohariwala, was submitted to BSE Limited and the National Stock Exchange of India Limited. The filing lists five individuals — including two promoters and three promoter group members — as part of the promoter and PAC group.

powered bylight_fuzz_icon
39537344

*this image is generated using AI for illustrative purposes only.

On April 3, 2026, innova captab Limited submitted a regulatory declaration to BSE Limited and the National Stock Exchange of India Limited, confirming that its promoters and Persons Acting in Concert (PACs) have not created any encumbrance on their equity shareholding during the financial year ended March 31, 2026. The declaration was made under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and was digitally signed by promoter Vinay Lohariwala on behalf of all promoters and PACs.

Regulatory Declaration Details

Vinay Lohariwala, acting as promoter of Innova Captab Limited, confirmed that neither he nor any other promoter or PAC has made any encumbrance — directly or indirectly — on the equity shares held by them during the financial year ended March 31, 2026. The declaration was addressed to BSE Limited, the National Stock Exchange of India Limited, and the Audit Committee of Innova Captab Limited. The filing was digitally signed on April 3, 2026, at 12:58:09 IST.

Promoters and Persons Acting in Concert

The declaration was accompanied by a list of promoters and PACs holding shares in the company. The following individuals are identified in the filing:

Sr. No.: Name: Category:
1. Manoj Kumar Lohariwala Promoter
2. Vinay Lohariwala Promoter
3. Vandana Lohariwala Promoter Group
4. Chhavi Lohariwala Promoter Group
5. Deendayal Choudhary Promoter Group

Filing Details

The declaration was submitted from the company's registered address at Plot No. 320, Industrial Area, Phase-1, Panchkula, Pin-134113, Haryana, India. The filing was made to both major Indian stock exchanges in compliance with the applicable SEBI regulatory framework governing substantial acquisition of shares and takeovers.

Historical Stock Returns for Innova Captab

1 Day5 Days1 Month6 Months1 Year5 Years
-1.04%+18.57%+23.47%+7.56%-2.32%+59.52%

Could the promoters' clean encumbrance record strengthen Innova Captab's position for securing institutional investments or strategic partnerships in the near future?

How might Innova Captab's consistent regulatory compliance influence its valuation and investor sentiment ahead of any potential secondary market offerings?

Are there any upcoming expansion plans or capital allocation strategies by Innova Captab's promoters that could signal changes in their shareholding structure in FY2027?

Innova Captab Limited Schedules Earnings Call for Q4 FY26 Results Discussion on May 8, 2026

1 min read     Updated on 01 May 2026, 12:32 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Innova Captab Limited has officially announced its Q4 and FY26 earnings call scheduled for May 8, 2026 at 11:00 AM IST. The virtual meeting will be conducted by key leadership including Managing Director Vinay Lohariwala and CFO Lokesh Bhasin to discuss audited financial results with analysts and institutional investors, coordinated by Strategic Growth Advisors.

powered bylight_fuzz_icon
39080353

*this image is generated using AI for illustrative purposes only.

Innova Captab Limited has announced its earnings call to discuss the operational and financial performance for Q4 and FY26. The company has scheduled a virtual meeting with analysts and institutional investors to review the audited financial results for the quarter and financial year ended March 31, 2026.

Earnings Call Details

The pharmaceutical company has provided comprehensive details for the upcoming earnings call through its regulatory filing dated April 30, 2026.

Parameter: Details
Date: Friday, May 8, 2026
Time: 11:00 AM IST
Mode: Virtual Meeting
Participants: Group of Investors and Analysts
Purpose: Discussion of Q4 & FY26 Results

Regulatory Compliance

The announcement has been made pursuant to Regulation 30 read with Schedule III Part A – Para A (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has formally notified both stock exchanges about this scheduled interaction.

Stock Exchange Notifications:

  • BSE Limited (Symbol: INNOVACAP, Scrip Code: 544067)
  • National Stock Exchange of India Limited (Symbol: INNOVACAP)

Company Representatives

The earnings call will feature key leadership members who will present and discuss the company's financial performance:

  • Mr. Vinay Lohariwala – Managing Director
  • Mr. Lokesh Bhasin – Chief Financial Officer

Access Information

The company has provided multiple access options for participants, including primary numbers and international toll-free numbers for various regions.

Access Type: Contact Numbers
Primary Numbers: +91 22 6280 1309, +91 22 7115 8210
USA Toll Free: 1 866 746 2133
UK Toll Free: 0 808 101 1573
Singapore Toll Free: 800 101 2045
Hong Kong Toll Free: 800 964 448

Event Coordination

Strategic Growth Advisors Pvt. Ltd. is coordinating the earnings call, with Ms. Shaily Patwa and Mr. Shrikant Sangani serving as the primary contacts. The company has requested participants to pre-register for the call and noted that changes may occur due to exigencies on the part of participants or the company.

The filing was signed by Neeharika Shukla, Company Secretary and Compliance Officer, and submitted to maintain transparency with stakeholders regarding the scheduled investor interaction.

Historical Stock Returns for Innova Captab

1 Day5 Days1 Month6 Months1 Year5 Years
-1.04%+18.57%+23.47%+7.56%-2.32%+59.52%

What key growth initiatives or strategic partnerships might Innova Captab announce during the earnings call to drive FY27 performance?

How will potential regulatory changes in the pharmaceutical sector impact Innova Captab's product pipeline and market expansion plans?

What market share gains or competitive positioning improvements could the company highlight for its core therapeutic segments?

More News on Innova Captab

1 Year Returns:-2.32%